Fig. 2
From: Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children
Clinical characteristics of subjects and urine proteome changes. A Gender distribution of cohort 1 and cohort 2. B Age distribution of cohort 1 and cohort 2. CAnalysis of albumin proportion to total proteins in urine samples. D Analysis of urine samples contaminated with erythrocytes. E The correlation analysis of 12 QC samples by Pearson correlation coefficient. F The number of identified proteins in RN0, RN1, RS0, RS1, HC, and QC groups. RMS: rhabdomyosarcoma. HC healthy control, QC quality control samples, RN0 newly diagnosed RMS at the time points of admission, RN1 newly diagnosed RMS at the time points after 4 cycles of chemotherapy, RS0 RMS underwent surgery at the time points of admission, RS1 RMS underwent surgery at the time points after 4 cycles of chemotherapy